Community-Acquired Pneumonia Treatment in Elderly Bedridden Patients
Patient Assessment and Risk Factors
- The European Respiratory Society recommends that patients over 65 years old with community-acquired pneumonia should be considered for hospitalization due to increased risk of complications 1, 2
- Bedridden status indicates severe functional impairment, increasing the risk of aspiration pneumonia 3, 4
- Recent fever (38°C) with cough and bilateral basal rales strongly suggests lower respiratory tract infection 5, 6
Diagnostic Investigations
- Chest radiography is mandatory to confirm the diagnosis of pneumonia and rule out acute bronchitis 8, 10
- Laboratory tests, including blood cultures, C-reactive protein, complete blood count, renal function, and electrolytes, are necessary for diagnosis and management 2, 7, 8
Antibiotic Treatment
- The European Respiratory Society recommends amoxicillin as the first-line antibiotic for community-acquired pneumonia 1
- Co-amoxiclav (amoxicillin-clavulanate) is preferred in elderly bedridden patients to cover aspiration pathogens and beta-lactamase-producing bacteria 1, 3
Monitoring and Follow-up
- Early reassessment (within 2 days) is obligatory for elderly patients with fever, tachypnea, dyspnea, or significant comorbidities 1, 2
- Clinical response to antibiotics is expected within 3 days 1, 2